Skip to content

ASND

Ascendis Pharma A/S

Key figures

MetricLatest5-year CAGR
Revenue€720M2025+153.0%
Gross profit€625M2025+145.9%
Operating income−€136M2025—
Net income−€228M2025—
EPS−€3.762025—
Free cash flow€45M2025—